Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.

[1]  M. Ladanyi,et al.  Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma , 2018, JAMA oncology.

[2]  B. Shuch,et al.  Hereditary Kidney Cancer Syndromes and Surgical Management of the Small Renal Mass. , 2017, The Urologic clinics of North America.

[3]  C. Lallas,et al.  Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts , 2017, Journal of genetic counseling.

[4]  S. Bojesen,et al.  Increased Risk for Other Cancers in Addition to Breast Cancer for CHEK2*1100delC Heterozygotes Estimated From the Copenhagen General Population Study. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Pautler,et al.  Structured assessment and followup for patients with hereditary kidney tumour syndromes. , 2016, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[6]  B. Rosen,et al.  Genetic testing for BRCA1 and BRCA2 in the Province of Ontario , 2016, Clinical genetics.

[7]  S. Pautler,et al.  Knowledge of genetic testing for hereditary kidney cancer in Canada is lacking: The results of the Canadian national hereditary kidney cancer needs assessment survey. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[8]  R. Bennett,et al.  A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment , 2014, Genetics in Medicine.

[9]  W. Linehan,et al.  Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  S. Pautler,et al.  Canadian guideline on genetic screening for hereditary renal cell cancers. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[11]  Wong-Ho Chow,et al.  Epidemiology and risk factors for kidney cancer , 2010, Nature Reviews Urology.

[12]  J. Cheville,et al.  Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. , 2010, The Journal of urology.

[13]  J. Lubiński,et al.  CHEK2 is a multiorgan cancer susceptibility gene. , 2004, American journal of human genetics.

[14]  R. R. Lonser,et al.  von Hippel-Lindau disease , 2003, The Lancet.

[15]  P L Choyke,et al.  Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. , 1999, The Journal of urology.